VITAL-Bone Health: Rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL)

Contemporary Clinical Trials

Volumn 41, Issue , 2015, Pages 259-268

  LeBoff, Meryl S ^a   Yue, Amy Y ^a   Copeland, Trisha ^a   Cook, Nancy R ^a,b   Buring, Julie E ^a,b   Manson, JoAnn E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone mineral density; Bone turnover; Fractures; Omega 3 fatty acids; Trabecular bone score; Vitamin D

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; OMEGA 3 FATTY ACID; OSTEOCALCIN; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE STRUCTURE; BONE TURNOVER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; COMPUTER ASSISTED TOMOGRAPHY; DIETARY SUPPLEMENT; FEMUR; FRACTURES, BONE; HIP; MIDDLE AGED; PHOTON ABSORPTIOMETRY; RADIOGRAPHY;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FEMUR; FRACTURES, BONE; HIP JOINT; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922964704     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.01.007     Document Type: Article

References (76)

1. Wright N.C., Looker A.C., Saag K.G., Curtis J.R., Delzell E.S., Randall S., et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014, 29(11):2520-2526.
2. Looker A.C., Johnson C.L., Lacher D.A., Pfeiffer C.M., Schleicher R.L., Sempos C.T. Vitamin D status: United States. NCHS Data Brief 2001-2006, 2011(59):1-8. [Epub 2011/05/20. PubMed PMID: 21592422].
3. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985, 76(4):1536-1538. [Epub 1985/10/01. PubMed PMID: 2997282; PubMed Central PMCID: PMC424123]. 10.1172/JCI112134.
4. Harris S.S. Vitamin D and African Americans. J Nutr 2006, 136(4):1126-1129. [PMID: 16549493].
5. Harris S.S., Dawson-Hughes B. Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. J Clin Endocrinol Metab 2007, 92(8):3155-3157. [Epub 2007/05/31. jc.2007-0722 [pii]. PubMed PMID: 17535990]. 10.1210/jc.2007-0722.
6. Barrett-Connor E., Laughlin G.A., Li H., Nielson C.M., Wang P.Y., Dam T.T., et al. Osteoporotic fractures in men research G. J Bone Miner Res 2012, 27(11):2306-2313. [PubMed PMID: 22777902; PubMed Central PMCID: PMC3474871]. 10.1002/jbmr.1697.
7. Rouzi A., Al-Sibiani S., Al-Senani N., Radaddi R., Ardawi M. Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study. Bone 2012, 50(3):713-722.
8. De Boer I., Levin G., Robinson-Cohen C., Biggs M., Hoofnagle A., Siscovick D., et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med 2012, 156(9):627-634. [PubMed Central PMCID: PMC22547472].
9. Robinson-Cohen C., Katz R., Hoofnagle A.N., Cauley J.A., Furberg C.D., Robbins J.A., et al. Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab 2011, 96(7):2186-2193. [PubMed PMID: 21508146; PubMed Central PMCID: PMC3135189]. 10.1210/jc.2010-2878.
10. Cauley J.A., Danielson M.E., Boudreau R., Barbour K.E., Horwitz M.J., Bauer D.C., et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the women's health initiative (WHI). J Bone Miner Res Off J Am Soc Bone Miner Res 2011, 26(10):2378-2388. [Epub 2011/09/29. PubMed PMID: 21710614]. 10.1002/jbmr.449.
11. Looker A.C., Mussolino M.E. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res 2008, 23(1):143-150. [Epub 2007/10/03. PubMed PMID: 17907920]. 10.1359/jbmr.071003.
12. Cauley J.A., Lacroix A.Z., Wu L., Horwitz M., Danielson M.E., Bauer D.C., et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008, 149(4):242-250. [PubMed PMID: 18711154].
13. Bailey R.L., Dodd K.W., Goldman J.A., Gahche J.J., Dwyer J.T., Moshfegh A.J., et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010, 140(4):817-822. 10.3945/jn.109.118539.
14. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med N Engl J Med. 1992, 327(23):1637-1642. [PubMed PMID: 1331788].
15. Chapuy M.C., Pamphile R., Paris E., Kempf C., Schlichting M., Arnaud S., et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002, 13(3):257-264. [PubMed PMID: 11991447].
16. Prentice R.L., Pettinger M.B., Jackson R.D., Wactawski-Wende J., Lacroix A.Z., Anderson G.L., et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 2013, 24(2):567-580. [PubMed PMID: 23208074; PubMed Central PMCID: PMC3557387]. 10.1007/s00198-012-2224-2.
17. Larsen E.R., Mosekilde L., Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004, 19(3):370-378. [PubMed PMID: 15040824]. 10.1359/JBMR.0301240.
18. Lips P., Graafmans W., Ooms M., Bezemer P., Bouter L. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996, 124(4):400-406.
19. Meyer H.E., Smedshaug G.B., Kvaavik E., Falch J.A., Tverdal A., Pedersen J.I. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002, 17(4):709-715. [Epub 2002/03/29. PubMed PMID: 11918228]. 10.1359/jbmr.2002.17.4.709.
20. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326(7387):469. [PubMed PMID: 12609940].
21. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293(18):2257-2264. [PubMed PMID: 15886381].
22. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354(7):669-683. [PubMed PMID: 16481635].
23. Boonen S., Lips P., Bouillon R., Bischoff-Ferrari H.A., Vanderschueren D., Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007, 92(4):1415-1423. [Epub 2007/02/01. jc.2006-1404 [pii]. PubMed PMID: 17264183]. 10.1210/jc.2006-1404.
24. Tang B.M., Eslick G.D., Nowson C., Smith C., Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50years and older: a meta-analysis. Lancet 2007, 370(9588):657-666. [Epub 2007/08/28. S0140-6736(07)61342-7 [pii]. PubMed PMID: 17720017]. 10.1016/S0140-6736(07)61342-7.
25. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169(6):551-561. [Epub 2009/03/25. 169/6/551 [pii]. PubMed PMID: 19307517]. 10.1001/archinternmed.2008.600.
26. Avenell A., Mak J.C., O'Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014, 4. CD000227.
27. DIPART Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010, 340:b5463. [Epub 2010/01/14. bmj.b5463 [pii]. PubMed PMID: 20068257; PubMed Central PMCID: PMC2806633]. 10.1136/bmj.b5463.
28. Chung M., Lee J., Terasawa T., Lau J., Trikalinos T.A. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 155(12):827-838. [PubMed PMID: 22184690]. 10.7326/0003-4819-155-12-201112200-00005.
29. Bischoff-Ferrari H.A., Willett W.C., Orav E.J., Lips P., Meunier P.J., Lyons R.A., et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367(1):40-49. [Epub 2012/07/06. PubMed PMID: 22762317]. 10.1056/NEJMoa1109617.
30. Moyer V.A. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 2013, 158(9):691-696. on behalf of the USPSTF.
31. Newberry S., Shekelle P., Booth M.S., Liu J., Maher A., Motala A., et al. Vitamin D and calcium: a systematic review of health outcome (update) 2014, Agency for Healthcare Research and Quality (AHRC).
32. Reid I.R., Bolland M.J., Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014, 383(9912):146-155.
33. Theodoratou E., Tzoulaki I., Zgaga L., Ioannidis J.P. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014, 348:g2035.
34. Sanders K., Stuart A., Williamson E., Simpson J., Kotowicz M., Young D., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303(18):1815-1822.
35. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18(7):1206-1216. [Epub 2003/07/12. PubMed PMID: 12854830].
36. Matsushita H., Barrios J.A., Shea J.E., Miller S.C. Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab 2008, 26(3):241-247. [Epub 2008/05/13. PubMed PMID: 18470664]. 10.1007/s00774-007-0815-3.
37. Bonnet N., Ferrari S. A long-term diet enriched in omega-3 fatty acids improves cortical bone structure and mechanical properties in mice. New frontiers in skeletal research: bone, Fat, and brain connections 2009, Abstract#M47, Bethesda, [MDApril 27-28].
38. Salari P., Rezaie A., Larijani B., Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008, 14(3):RA37-RA44. [Epub 2008/02/28. 836571 [pii]. PubMed PMID: 18301367].
39. Sakaguchi K., Morita I., Murota S. Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 1994, 50(2):81-84. [Epub 1994/02/01. PubMed PMID: 8171071].
40. Yamada Y., Fushimi H., Inoue T., Matsuyama Y., Kameyama M., Minami T., et al. Effect of eicosapentaenoic acid and docosahexaenoic acid on diabetic osteopenia. Diabetes Res Clin Pract 1995, 30(1):37-42. [Epub 1995/10/01. 0168822795011390 [pii]. PubMed PMID: 8745204].
41. Reinwald S., Li Y., Moriguchi T., Salem N., Watkins B.A. Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats. J Nutr 2004, 134(2):388-394. [Epub 2004/01/30. PubMed PMID: 14747677].
42. Watkins B.A., Li Y., Lippman H.E., Feng S. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 2003, 68(6):387-398. [Epub 2003/06/12. S0952327803000632 [pii]. PubMed PMID: 12798659].
43. Watkins B.A., Li Y., Lippman H.E., Seifert M.F. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood) 2001, 226(6):485-497. [Epub 2001/06/09. PubMed PMID: 11395919].
44. Weiss L.A., Barrett-Connor E., von Muhlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 2005, 81(4):934-938. [Epub 2005/04/09. 81/4/934 [pii]. PubMed PMID: 15817874].
45. Van Papendrop D.H., Coetzer H., Kruger M.G. Biochemical profile of osteoporotic patients on essential fatty acid supplementation. Nutr Res 1995, 15:325-334.
46. Farina E.K., Kiel D.P., Roubenoff R., Schaefer E.J., Cupples L.A., Tucker K.L. Dietary intakes of arachidonic acid and {alpha}-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr 2011, 141(6):1146-1153. [Epub 2011/04/22. PubMed PMID: 21508210; PubMed Central PMCID: PMC3095142]. 10.3945/jn.110.133728.
47. Orchard T.S., Ing S.W., Lu B., Belury M.A., Johnson K., Wactawski-Wende J., et al. The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative. J Bone Miner Res 2013, 28(3):505-515. [Epub 2012/09/29. PubMed PMID: 23018646; PubMed Central PMCID: PMCPMC3785326]. 10.1002/jbmr.1772.
48. Farina E.K., Kiel D.P., Roubenoff R., Schaefer E.J., Cupples L.A., Tucker K.L. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2011, 93(5):1142-1151. [Epub 2011/03/04. PubMed PMID: 21367955; PubMed Central PMCID: PMC3076660]. 10.3945/ajcn.110.005926.
49. Manson J.E., Bassuk S.S., Lee I.M., Cook N.R., Albert M.A., Gordon D., et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2011, [Epub 2011/10/12. S1551-7144(11)00245-X [pii]. PubMed PMID: 21986389]. 10.1016/j.cct.2011.09.009.
50. Institute of Medicine Dietary reference intakes for calcium and vitamin D. 2011, National Academies Press. http://www.iom.edu/vitaminD.
51. Rinaldi G., Wisniewski C.A., Setty N.G., Leboff M.S. Peripheral quantitative computed tomography: optimization of reproducibility measures of bone density, geometry, and strength at the radius and tibia. J Clin Densitom 2011, 14(3):367-373. [Epub 2011/07/05. S1094-6950(11)00114-4 [pii]. PubMed PMID: 21723765]. 10.1016/j.jocd.2011.05.002.
52. Hans D., Goertzen A.L., Krieg M.A., Leslie W.D. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 2011, 26(11):2762-2769. [PubMed PMID: 21887701]. 10.1002/jbmr.499.
53. Micklesfield L.K., Goedecke J.H., Punyanitya M., Wilson K.E., Kelly T.L. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity (Silver Spring) 2012, 20(5):1109-1114. [Epub 2012/01/14. PubMed PMID: 22240726; PubMed Central PMCID: PMCPMC3343346]. 10.1038/oby.2011.367.
54. Studenski S.A., Peters K.W., Alley D.E., Cawthon P.M., McLean R.R., Harris T.B., et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014, 69:547-558. [Epub 2014/04/17. PubMed PMID: 24737557; PubMed Central PMCID: PMCPMC3991146]. 10.1093/gerona/glu010.
55. Guralnik J.M., Ferrucci L., Pieper C.F., Leveille S.G., Markides K.S., Ostir G.V., et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000, 55(4):M221-M231. [Epub 2000/05/16. PubMed PMID: 10811152].
56. LeBoff M.S., Shoback D., Brown E.M., Thatcher J., Leombruno R., Beaudoin D., et al. Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest 1985, 75(1):49-57. [Epub 1985/01/01. PubMed PMID: 3965511; PubMed Central PMCID: PMC423397]. 10.1172/JCI111696.
57. LeBoff M.S., Kohlmeier L., Hurwitz S., Franklin J., Wright J., Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999, 281(16):1505-1511. [PubMed PMID: 10227320].
58. Haden S.T., Fuleihan G.E., Angell J.E., Cotran N.M., LeBoff M.S. Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Int 1999, 64(4):275-279. [PubMed PMID: 10089217].
59. Brent G.A., LeBoff M.S., Seely E.W., Conlin P.R., Brown E.M. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 1988, 67(5):944-950. [Epub 1988/11/01. PubMed PMID: 3141451].
60. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359(9319):1761-1767. [Epub 2002/06/07. S0140-6736(02)08657-9 [pii]. PubMed PMID: 12049882]. 10.1016/S0140-6736(02)08657-9.
61. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., Ensrud K.E., et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332(12):767-773. [PubMed PMID: 7862179].
62. Orwoll E., Blank J.B., Barrett-Connor E., Cauley J., Cummings S., Ensrud K., et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005, 26(5):569-585. [Epub 2005/08/09. S1551-7144(05)00107-2 [pii]. PubMed PMID: 16084776]. 10.1016/j.cct.2005.05.006.
63. Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982, 1(2):121-129. [PubMed PMID: 7187087].
64. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65years of age or older. N Engl J Med 1997, 337(10):670-676. [PubMed PMID: 9278463].
65. Pietrogrande L., Raimondo E., Fossali A., Zaolino C. Biological and pharmacological factors influencing the fracture healing. Aging Clin Exp Res 2011, 23(2 Suppl):65-68. [Epub 2011/10/06. doi: 7956 [pii]. PubMed PMID: 21970928].
66. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96(1):53-58. [Epub 01/2011]. 10.1210/jc.2010-2704.
67. Dawson-Hughes B. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 2008, 93(7):2463-2465. [PubMed PMID: 18544615].
68. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22(3):465-475. [PubMed PMID: 17144789].
69. Chun R.F., Adams J.S., Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol 2008, 198(2):261-269. [Epub 2008/05/23. JOE-08-0170 [pii] PubMed PMID: 18495944]. 10.1677/JOE-08-0170.
70. Dawson-Hughes B., Mithal A., Bonjour J.P., Boonen S., Burckhardt P., Fuleihan G.E., et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010, 21(7):1151-1154. [Epub 2010/04/28. PubMed PMID: 20422154]. 10.1007/s00198-010-1285-3.
71. Cosman F., Lindsay R., LeBoff M.S., de Beur S.J., Tanner B. Clinician's guide to prevention and treatment of osteoporosis 2014, National Osteoporosis Foundation, Washington, DC.
72. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(7):1911-1930. [PubMed PMID: 21646368]. 10.1210/jc.2011-0385.
73. Moore C.E., Murphy M.M., Holick M.F. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 2005, 135(10):2478-2485. [PubMed PMID: 16177216].
74. Powe C.E., Evans M.K., Wenger J., Zonderman A.B., Berg A.H., Nalls M., et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013, 369(21):1991-2000.
75. Powe C.E., Ricciardi C., Berg A.H., Erdenesanaa D., Collerone G., Ankers E., et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011, 26(7):1609-1616. [PubMed PMID: 21416506; PubMed Central PMCID: PMC3351032]. 10.1002/jbmr.387.
76. Bhan I., Powe C.E., Berg A.H., Ankers E., Wenger J.B., Karumanchi S.A., et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int 2012, 82(1):84-89. [Epub 2012/03/09. PubMed PMID: 22398410; PubMed Central PMCID: PMC3376220]. 10.1038/ki.2012.19.